CAS No. |
514-47-6 |
中文名称 |
4,4,10,13,14-五甲基-17-(6-甲基庚-5-烯-2-基)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-3-醇 |
英文名称 |
4,4,10,13,14-pentamethyl-17-(6-methylhept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
别名 |
(+)-Euphol | (s)-euphol | HY-N0313 | Q27106574 | (20R)-(+)-triucalla-8,24-diene-3beta-ol | (3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | A871282 | al |
标准英文名 |
4,4,10,13,14-pentamethyl-17-(6-methylhept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
MDL No. |
MFCD01716323 |
分子式 |
C30H50O |
分子量 |
426.73
|
精确分子量 |
426.39
|
SMILES |
CC(C)=CCCC(C)C1CCC2(C)C3=C(CCC12C)C1(C)CCC(O)C(C)(C)C1CC3 |
标准SMILES |
CC1(C)C(O)CCC2(C)C1CCC1=C2CCC2(C)C(CCC21C)C(C)CCC=C(C)C |
用途 |
Euphol exhibits anti-inflammatory and immunomodulatory activities with oral bioavailability; it inhibits monoacylglycerol lipase (MGL) reversibly (IC50 = 315 nM), thereby modulating the endocannabinoid system to prevent inflammatory pain; it also demonstrates antihypertensive effects and inhibits the proliferation of T47D breast cancer cells by inducing cell cycle arrest through upregulation of p21 and p27 and downregulation of cyclins A, B1, and D. |
InChIKey |
CAHGCLMLTWQZNJ-UHFFFAOYSA-N |